DR. PAUL BILLINGS, M.D., PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cardiff Oncology, Inc.

Filing Date Source Excerpt
2017-04-28 Dr. Billings holds an M.D. from Harvard Medical School and a Ph.D. in immunology, also from Harvard University. The Board believes that Dr. Billings’ medical and managerial experience in the diagnostic field qualifies him to serve as a director of our company.

Data sourced from SEC filings. Last updated: 2026-02-03